Abstract:The medical history of cancer began millennia ago. Historical findings of patients with cancer date back to ancient Egyptian and Greek civilizations, where this disease was predominantly treated with radical surgery and cautery that were often ineffective, leading to the death of patients. Over the centuries, important discoveries allowed to identify the biological and pathological features of tumors, without however contributing to the development of effective therapeutic approaches until the end of the 1800s, when the discovery of X-rays and their use for the treatment of tumors provided the first modern therapeutic approach in medical oncology. However, a real breakthrough took place after the Second World War, with the discovery of cytotoxic antitumor drugs and the birth of chemotherapy for the treatment of various hematological and solid tumors. Starting from this epochal turning point, there has been an exponential growth of studies concerning the use of new drugs for cancer treatment. The second fundamental breakthrough in the field of oncology and pharmacology took place at the beginning of the '80s, thanks to molecular and cellular biology studies that allowed the development of specific drugs for some molecular targets involved in neoplastic processes, giving rise to targeted therapy. Both chemotherapy and target therapy have significantly improved the survival and quality of life of cancer patients inducing sometimes complete tumor remission. Subsequently, at the turn of the third millennium, thanks to genetic engineering studies, there was a further advancement of clinical oncology and pharmacology with the introduction of monoclonal antibodies and immune checkpoint inhibitors for the treatment of advanced or metastatic tumors, for which no effective treatment was available before. Today, cancer research is always aimed at the study and development of new therapeutic approaches for cancer treatment. Currently, several researchers are focused on the development of cell therapies, anti-tumor vaccines, and new biotechnological drugs that have already shown promising results in preclinical studies, therefore, in the near future, we will certainly assist to a new revolution in the field of medical oncology.

With one eye on the future

Digital oncology, the dawn of a new era turning the clock back on tumor mass

A roadmap for the next decade in cancer research

Cancer Immunotherapy: an Evolving Paradigm

Today's cancer research and treatment - highly sophisticated and molecularly targeted, yet firmly bolstered in the classical theories

Two decades of advances in clinical oncology — lessons learned and future directions

A New Era of Data-Driven Cancer Research and Care: Opportunities and Challenges

Advancing to the era of cancer immunotherapy

The Next Big Questions in Cancer Research

A brand new era of cancer immunotherapy: breakthroughs and challenges

Five decades of advances in cancer research

Cancer Biology, Epidemiology, and Treatment in the 21st Century: Current Status and Future Challenges From a Biomedical Perspective

Personalized Medicine: Recent Progress in Cancer Therapy

Cancer Nanomedicines in an Evolving Oncology Landscape

Pan-Cancer Molecular Biomarkers: A Paradigm Shift in Diagnostic Pathology

Advancing Access and Equity: the Vision of a New Generation in Cancer Control.

Blueprint for cancer research: Critical gaps and opportunities

Recent advances in lung cancer research: unravelling the future of treatment

New horizons in tumor microenvironment biology: challenges and opportunities

Unveiling the pan-cancer landscape of S100A16: A comprehensive analysis of prognostic significance, drug sensitivity, and immunomodulatory roles

Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium